昭衍新药 (603127.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(昭衍新药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年第四季度2025年第三季度2025年第二季度2025年第一季度2024年第四季度2024年第三季度2024年第二季度2024年第一季度
单季度财务指标:
 单季度销售毛利率(%) 会员可见会员可见会员可见会员可见30.0022.0029.0033.00
 单季度销售净利率(%) 会员可见会员可见会员可见会员可见21.0020.0019.00-84.00
 单季度净资产收益率ROE(%) 会员可见--会员可见2.001.001.00-3.00
 单季度总资产净利率ROA(%) 会员可见---2.001.001.00-3.00
单季度财务摘要:
 单季度营业总收入(元) 会员可见会员可见会员可见会员可见683,177,721.00485,799,506.00524,547,440.00324,809,104.00
 单季度营业总成本(元) 会员可见会员可见会员可见会员可见536,014,090.00474,671,792.00459,767,812.00293,294,647.00
 单季度营业收入(元) 会员可见会员可见会员可见会员可见683,177,721.00485,799,506.00524,547,440.00324,809,104.00
 单季度营业利润(元) 会员可见会员可见会员可见会员可见174,008,323.00107,493,728.00115,853,533.00-293,008,275.00
 单季度利润总额(元) 会员可见会员可见会员可见会员可见173,931,343.00107,458,838.00115,778,908.00-293,130,016.00
 单季度净利润(元) 会员可见会员可见会员可见会员可见143,999,074.0097,994,306.00101,125,287.00-273,363,603.00
 单季度归属母公司股东的净利润(元) 会员可见会员可见会员可见会员可见144,382,460.0099,435,566.00102,479,834.00-272,222,475.00
 单季度经营活动产生的现金流量(元) 会员可见会员可见会员可见会员可见146,603,009.0034,609,066.0037,763,124.00119,953,519.00
 单季度投资活动产生的现金流量(元) 会员可见会员可见会员可见会员可见-1,012,973,219.00-204,378,807.00-678,109,661.00-67,562,299.00
 单季度筹资活动产生的现金流量(元) 会员可见会员可见会员可见会员可见-16,799,395.00-141,577,836.00-69,321,892.00-37,928,364.00
 单季度现金及现金等价物净增加(元) 会员可见会员可见会员可见会员可见-874,921,383.00-318,070,633.00-707,119,011.0011,667,128.00

前瞻产业研究院